• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Lab Owner Pleads Guilty to $89 Million Fraud Scheme

Lab Owner Pleads Guilty to $89 Million Fraud Scheme

by Rachel Muenz | Mar 29, 2023 | News, Open Content

Last week saw two key lab-related cases, with the biggest involving a fraud scheme relating to cancer genetic testing.

Weekly Enforcement Report: Lab Owners Charged in 2 Fraud Schemes

Weekly Enforcement Report: Lab Owners Charged in 2 Fraud Schemes

by Rachel Muenz | Mar 15, 2023 | News, Open Content

The owners face fraud charges in two different schemes, one involving urine drug testing and one involving COVID-19 testing.

Labs Should Be Wary of Improper Billing of G0483 Testing

Labs Should Be Wary of Improper Billing of G0483 Testing

by Glenn S. Demby | Mar 10, 2023 | News, Open Content

Recent OIG report says Medicare could have saved up to $215.8 million on at-risk payments for G0483 definitive drug tests.

Weekly Enforcement Report: Medical Centers Pay Big

Weekly Enforcement Report: Medical Centers Pay Big

by Rachel Muenz | Mar 8, 2023 | News, Open Content

Recently announced enforcement actions saw three big settlements, with two of those coming from medical centers.

Weekly Enforcement Report: All Quiet on the Laboratory Front

Weekly Enforcement Report: All Quiet on the Laboratory Front

by Rachel Muenz | Mar 1, 2023 | News, Open Content

Though labs were again absent from recent key enforcement actions, sentences were handed down in other healthcare-related cases.

« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com